Cita APA (7a ed.)

Haase, D., Stevenson, K., Neuberg, D., Maciejewski, J., Nazha, A., Sekeres, M., . . . Committee, I. W. G. F. M. M. P. (2019). TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Springer Nature.

Cita Chicago Style (17a ed.)

Haase, D., et al. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Springer Nature, 2019.

Cita MLA (9a ed.)

Haase, D., et al. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Springer Nature, 2019.